About the Role:
FL117, a venture-backed stealth AI x bio company, is seeking a Sr. Scientist / Principal Scientist, Molecular Simulations. Here you will build the physics layer of a drug development AI platform. You will characterize how binders engage their targets and validate generated designs before they are committed to synthesis. You will work at the interface of structure-based modeling and generative ML, turning simulation output into training signals. We are looking for a hands-on simulation scientist who is comfortable owning a method end to end in a cross-functional, fast-moving team.
Responsibilities:
- Binder Characterization: Run and interpret structural and dynamic analysis of ligand–target complexes peptides, macrocycles, nanobodies/VHHs, antibody CDRs.
- Pocket & Target Assessment: Characterize binding sites, including cryptic and induced-fit pockets, across the target portfolio using MD, enhanced sampling, and pocket detection methods.
- Design Validation: Triage generated molecules before synthesis through a combination of pose prediction and refinement, docking rescoring, binding-mode stability under MD, ligand strain and conformational ensemble analysis, and define the criteria by which a design advances or gets killed.
- Free Energy & Affinity Prediction: Build, validate, and own the affinity prediction workflow (relative and absolute FEP, MM-GBSA/PBSA, endpoint methods); establish its accuracy and applicability domain against measured data and report both honestly.
- Beyond-Rule-of-5 Properties: Model conformational behavior, intramolecular hydrogen bonding, chameleonicity, and membrane partitioning for macrocycles and other non-classical chemotypes to support oral property design.
- Simulation-to-ML Interface: Convert simulation output into structured signal for the generative platform in close partnership with the AI/ML team.
- Infrastructure & Throughput: Build reproducible, automated simulation pipelines on GPU cloud or HPC infrastructure; own system setup, parameterization, QC, and analysis at portfolio scale rather than one system at a time.
- Cross-functional Partnership: Work directly with medicinal chemistry, pharmacology, and external structural biology and assay partners; turn structural hypotheses into testable designs, feed returning data back into corrected models, and flag clearly where predictions are unreliable.
Must-have Qualifications:
- PhD in computational chemistry, biophysics, chemical physics, structural biology, or a related field; MSc with equivalent industry depth considered
- 4+ years of post-PhD molecular simulation experience, at least part of it in a drug discovery setting (Sr. Scientist); 6+ years with demonstrated ownership of a method or platform (Principal)
- Deep hands-on expertise in classical molecular dynamics: force fields and small molecule parameterization (AMBER/CHARMM/OPLS, GAFF/OpenFF), solvation and ion treatment, equilibration protocols, and the characteristic failure modes of each.
- Production experience with at least one enhanced sampling or free energy framework (relative or absolute FEP/TI, metadynamics, umbrella sampling, replica exchange, or weighted-ensemble MD) including validation against measured affinities.
- Structure-based drug design fundamentals: docking and pose evaluation, pharmacophore and hot-spot analysis, and critical assessment of experimental and predicted structures.
- Strong Python, with fluency in simulation toolchains (OpenMM, GROMACS, AMBER, NAMD, or Desmond) and analysis stacks (MDAnalysis/MDTraj, RDKit); version control and reproducible workflows as habit, not aspiration.
- Demonstrated ability to run simulations at scale on GPU, HPC, or cloud infrastructure through automation rather than manual per-system setup.
- Judgment about method cost versus decision value: able to say when a multi-week free energy campaign is warranted and when docking plus a short MD run is enough.
- Consistent record of outstanding technical output reflected in publications, patents, or high impact internal reports
Preferred Experience:
- Peptide, macrocycle, or other beyond-Rule-of-5 simulation: conformational ensembles, intramolecular hydrogen bonding, chameleonicity, and membrane permeability (ex: water-to-membrane transfer free energies).
- Experienced with target classes such as: GPCRs, protein–protein interactions, transcription factors, highly dynamic target classes.
- Working with predicted structures and their limitations (AlphaFold-class models, co-folding methods), and with cryptic or induced-fit pocket discovery.
- ML-adjacent simulation work: machine-learned force fields and potentials (ANI, MACE, NequIP-class), learned scoring functions, or generating simulation-derived features for downstream generative models.
- Workflow and infrastructure tooling: Snakemake/Nextflow, Airflow/Prefect/Dagster, Docker, AWS (Batch, ParallelCluster, S3), and experiment tracking (MLflow/W&B).
- Clear structural communication to non-specialists using PyMOL, ChimeraX, or Mol*. Please send a link to representative figures or your GitHub, if applicable.
- Strong presence in the computational chemistry or biophysics community through publications and conference proceedings. Please send a list of publications, if applicable.
ABOUT FLAGSHIP PIONEERING
Flagship Pioneering invents and builds platform companies, each with the potential for multiple products that transform human health, sustainability and beyond. Since its launch in 2000, Flagship has originated more than 100 companies. Many of these companies have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.
Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
At Flagship, we accept impossible missions to enable bigger leaps. Our core values guide us through uncertainty and toward lasting impact.
We are an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, protected veteran status, or any other characteristic protected by law.
We recognize that great candidates often bring unique strengths without fulfilling every qualification. If you have some of the experience listed above but not all, please apply anyway. We are dedicated to building diverse and inclusive teams and look forward to learning more about your background and interest in Flagship.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
#LI-MB1
Privacy Notice for Applicants: When you apply for a role at Flagship Pioneering or one of its portfolio companies, we collect and use personal information you provide (such as your name, contact details, work history, and application materials) to evaluate your application, communicate with you, and comply with legal obligations. Your application data is processed through Greenhouse, our applicant tracking system, and may also be reviewed using AI-assisted screening tools. We do not sell your personal information. California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information. If you are located in the EU or UK, we process your data under GDPR and you have rights to access, rectify, and erase your data. To exercise your rights or for questions, contact [email protected].
The salary range for this role is $146,000 - $236,500. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. FL117 currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on FL117's good faith estimate as of the date of publication and may be modified in the future.
Privacy Notice for Applicants: When you apply for a role at Flagship Pioneering or one of its portfolio companies, we collect and use personal information you provide (such as your name, contact details, work history, and application materials) to evaluate your application, communicate with you, and comply with legal obligations. Your application data is processed through Greenhouse, our applicant tracking system, and may also be reviewed using AI-assisted screening tools. We do not sell your personal information. California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information. If you are located in the EU or UK, we process your data under GDPR and you have rights to access, rectify, and erase your data. To exercise your rights or for questions, contact [email protected].
Skills Required
- PhD in computational chemistry, biophysics, chemical physics, structural biology, or a related field; an MSc with equivalent industry depth may be considered.
- At least 4 years of post-PhD molecular simulation experience, including some drug discovery experience for Senior Scientist level.
- At least 6 years of experience with demonstrated ownership of a method or platform for Principal Scientist level.
- Deep hands-on expertise in classical molecular dynamics, force fields, small-molecule parameterization, solvation, ion treatment, equilibration, and simulation failure modes.
- Production experience with at least one enhanced sampling or free-energy framework, including validation against measured affinities.
- Knowledge of structure-based drug design, docking, pose evaluation, pharmacophore analysis, hotspot analysis, and experimental or predicted structure assessment.
- Strong Python skills and fluency with molecular simulation and analysis toolchains.
- Experience running automated simulations at scale on GPU, HPC, or cloud infrastructure.
- Ability to evaluate method cost versus decision value in drug discovery workflows.
- Record of outstanding technical output through publications, patents, or high-impact internal reports.
- Experience simulating peptides, macrocycles, or other beyond-Rule-of-5 compounds.
- Experience with GPCRs, protein-protein interactions, transcription factors, or highly dynamic targets.
- Experience with predicted structures, co-folding methods, cryptic pockets, or induced-fit pocket discovery.
- ML-adjacent simulation experience, including machine-learned force fields, learned scoring functions, or simulation-derived features.
- Experience with workflow, infrastructure, containerization, AWS, or experiment-tracking tools.
- Ability to communicate structures to non-specialists using PyMOL, ChimeraX, or Mol*.
- Strong computational chemistry or biophysics publication and conference record.
Flagship Pioneering Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Flagship Pioneering and has not been reviewed or approved by Flagship Pioneering.
-
Fair & Transparent Compensation — Feedback suggests salary bands are visible for many Boston/Cambridge roles and pay is considered competitive for key scientific and leadership positions. Transparency in postings supports expectations that offers align with local biotech norms.
-
Healthcare Strength — Feedback suggests medical, dental, vision, disability, life insurance, HSA options, and mental-health coverage are comprehensive and well-regarded. Multiple items are employer-verified, reinforcing confidence in core health benefits.
-
Parental & Family Support — Feedback suggests maternity/paternity leave and family leave are offered at meaningful levels. These programs sit alongside paid holidays, sick days, and PTO to support family needs.
Flagship Pioneering Insights
What We Do
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).






